Apatinib: all 412 studies that test it
Page 4 of 5. Open to participants first (94), then studies with results posted, then the rest; newest registration first within each.
- Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT03298074Phase 2
- An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and GastricStatus unknownNCT03285906Phase 2/3
- Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT03276156Phase 1
- Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT03274011Phase 2
- Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)Status unknownNCT03271255Phase 2
- A Study of Apatinib Combined With S1 in Patients With Advanced Gastric CancerStatus unknownNCT03271073Phase 2
- A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT03267121Phase 2
- Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian CancerStatus unknownNCT03262545Phase 2
- Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical ResectionStatus unknownNCT03261791Phase 2
- Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLCTerminatedNCT03256721Phase 2
- Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric CancerStatus unknownNCT03255811Not applicable
- Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast CancerCompletedNCT03254654Phase 2
- A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic CholangiocarcinomaCompletedNCT03251443Phase 2
- Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell CarcinomaTerminatedNCT03251417Phase 2
- A Study To Test The Effect Of Apatinib On P450 EnzymesStatus unknownNCT03245307Phase 1
- Phase I Study of the Combination of Apatinib and POFStatus unknownNCT03244774Phase 1
- Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast CancerCompletedNCT03243838Phase 2
- Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid TumorsStatus unknownNCT03243643Phase 1
- Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric CancerStatus unknownNCT03229096Phase 2
- Apatinib for Resectable Colorectal CancerWithdrawnNCT03228043Not applicable
- Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard TreatmentStatus unknownNCT03224221Phase 2
- Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)Status unknownNCT03213587Phase 2
- Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer PatientsStatus unknownNCT03210064Phase 2
- Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCStatus unknownNCT03201146Phase 1/2
- A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid CancerStatus unknownNCT03199677Phase 2
- Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal CancerWithdrawnNCT03193814Phase 2
- Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT03193424Phase 2
- Apatinib in Refractory Colorectal CancerCompletedNCT03190616Phase 2
- Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer PatientsWithdrawnNCT03190239Phase 2
- Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal CarcinomaCompletedNCT03180476Phase 2
- Apatinib Treatment for Advanced Esophagus CancerStatus unknownNCT03170310Phase 2
- Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid CarcinomaStatus unknownNCT03167385Phase 2
- APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLCWithdrawnNCT03164694Phase 2
- Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.Status unknownNCT03163381Phase 2
- Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract CancersStatus unknownNCT03144856Phase 2
- Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.Status unknownNCT03144843Phase 2
- Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line ChemotherapyStatus unknownNCT03135977Phase 2
- Maintenance Treatment of Apatinib in Nasopharyngeal CarcinomaStatus unknownNCT03130270Phase 2
- The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung CancerStatus unknownNCT03129698Phase 2
- Mesylate Apatinib for Stage Ⅳ STS After Failure of ChemotherapyStatus unknownNCT03121846Phase 2
- Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJAStatus unknownNCT03116555Phase 2
- Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter TrialWithdrawnNCT03104335Phase 2
- Apatinib for the Elderly Advanced Gastric CancerCompletedNCT03104283Phase 2
- A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung CancerStatus unknownNCT03100955Phase 3
- A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck CancersStatus unknownNCT03096184Phase 2
- Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast CancerStatus unknownNCT03086785Phase 2
- A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer PatientsCompletedNCT03075462Phase 1
- A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ AdenocarcinomaStatus unknownNCT03071042Phase 1
- A Phase II Study of Apatinib in STS PatientsStatus unknownNCT03064243Phase 2
- Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung CancerStatus unknownNCT03050411Phase 1
- Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid CancerStatus unknownNCT03048877Phase 3
- Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)Status unknownNCT03046979Phase 2
- Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJAStatus unknownNCT03030937Phase 2
- Apatinib and Chemotherapy Sequential Treatment With Cervical CancerStatus unknownNCT03029013Not applicable
- A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer PatientsStatus unknownNCT03026881Phase 1
- The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric CancerStatus unknownNCT03007446Phase 2
- Apatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate CancerCompletedNCT02998242Not applicable
- Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)Status unknownNCT02995187Phase 2
- Apatinib for Advanced Non-squamous Head and Neck CancerStatus unknownNCT02989259Phase 2
- Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung CancerStatus unknownNCT02980809Phase 2
- Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard TreatmentCompletedNCT02976896Phase 2
- Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.CompletedNCT02945852Phase 2
- The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck CancerStatus unknownNCT02943252Phase 2
- Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic CarcinomaStatus unknownNCT02942693Phase 2
- Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric CancerStatus unknownNCT02942329Phase 1/2
- Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/CisplatinStatus unknownNCT02875457Phase 3
- ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following RadiotherapyTerminatedNCT02874651Phase 2
- Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian CancerCompletedNCT02867956Phase 2
- A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic CancerStatus unknownNCT02863367Phase 2
- Apatinib and Irinotecan in Treating Patients With Recurrent High-grade GliomaStatus unknownNCT02848794Phase 1/2
- Study of Apatinib and MASCT in Patients With Advanced Solid TumorsStatus unknownNCT02844881Phase 1/2
- Effect of Rifampicin on the Pharmacokinetics of ApatinibCompletedNCT02836821Phase 1
- Effect of Itraconazole on the Pharmacokinetics of ApatinibCompletedNCT02836171Phase 1
- A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR MutationsStatus unknownNCT02824458Phase 3
- Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung CancerStatus unknownNCT02780778Phase 2/3
- A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant ChemotherapyStatus unknownNCT02776527Phase 4
- A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT02775370Phase 2
- A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.Status unknownNCT02774200Phase 2
- A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment FailureStatus unknownNCT02772029Phase 1/2
- Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast CancerStatus unknownNCT02768415Phase 2
- Apatinib Dose Titration in Advanced or Metastatic Gastric CancerCompletedNCT02764268Not applicable
- The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung CancerStatus unknownNCT02733107Phase 2
- Study of Apatinib in Patients With Differentiated Thyroid CancerCompletedNCT02731352Phase 2
- A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma PatientsStatus unknownNCT02727309Phase 1/2
- Apatinib as Second-line Treatment of Advanced Pancreatic CancerStatus unknownNCT02726854Phase 2
- A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard TreatmentCompletedNCT02711969Phase 1
- Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal TherapyCompletedNCT02711007Phase 2/3
- Tarceva With or Without Apatinib in the Advanced Lung AdenocarcinomaStatus unknownNCT02704767Phase 2
- Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical StudyStatus unknownNCT02702323Phase 2/3
- Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric CancerStatus unknownNCT02697838Phase 2
- Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFRStatus unknownNCT02691871Phase 1
- Study of Apatinib in Metastatic Esophageal CancerStatus unknownNCT02683655Phase 2
- Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell CarcinomaCompletedNCT02645864Phase 1
- Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)Status unknownNCT02596256Phase 2
- Apatinib for Metastatic Esophageal Cancer.Status unknownNCT02544737Phase 2
- Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung CancerStatus unknownNCT02540824Phase 2
- Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric CancerStatus unknownNCT02537171Phase 3
- Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT02525237Phase 2
- The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT02515435Phase 2
- Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer CellsStatus unknownNCT02510469Phase 2/3